echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > Yu Hongjie's research team has made important progress in the research on the durability of the new crown inactivated vaccine and enhanced immunity

    Yu Hongjie's research team has made important progress in the research on the durability of the new crown inactivated vaccine and enhanced immunity

    • Last Update: 2021-12-30
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Recently, Fudan University School of Public Health, the Joint Task Force Yu Hongjie China Sinovac Biotech Co.


    There is a high correlation between the level of neutralizing antibodies induced by the new crown vaccine and the protective effect of the vaccine


    The results showed that for the 18-59-year-old population with an interval of 2 months between the second and third doses, compared with 28 days after the second dose, the neutralizing antibody level of the subjects was slightly increased 28 days after the third dose


    Figure 1: The level of neutralizing antibodies against the SARS-CoV-2 prototype strain in the adult group of 18-59 years old

    For people 60 years of age and older with an interval of 8 months between the second and third doses, the neutralizing antibody titer dropped to close to or below the positive detection threshold 6 months after the two doses of basic immunization


    The third dose of the vaccine was well tolerated and there was no difference compared with the first two doses


    Figure 2: Levels of neutralizing antibodies against SARS-CoV-2 prototype strains in adults 60 years and older

    Results of this study show that Kerr blessing ® is two times the basic immunization can produce a good immune memory


    In view of the important public health significance of this research, the journal invited Professor Julio Croda of the Federal University of Mato Grosso do Sul, Brazil, and Otavio T Ranzani, an epidemiologist at the Institute of Global Health in Barcelona, ​​Spain to "Booster doses for inactivated COVID-19 vaccines: "if, when, and for whom" as the topic, wrote an expert review


    Kexing Holding Biotechnology Co.


    In addition, the research group also co-Yu Hongjie Changping National Laboratory and the Beijing Ditan Hospital conducted a single center over 18 years of medical staff, open, randomized, controlled clinical trial to evaluate the completion of two times Kerr blessing ® foundation 4-8 months after immunization, the third vaccination doses Kerr fu ® or recombinant protein vaccine Zhi Fei (ZF2001) in 14 days and antibody levels


    Figure 3.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.